ImmunoGen Inc (NASDAQ:IMGN)

12.15
Delayed Data
As of Jun 22
 +0.47 / +4.02%
Today’s Change
4.80
Today|||52-Week Range
13.41
+89.55%
Year-to-Date
No recent news for ImmunoGen Inc.

Today’s Trading

Previous close11.68
Today’s open11.64
Day’s range11.39 - 12.17
Volume8,875,468
Average volume (3 months)3,001,814
Market cap$1.4B
Data as of 4:00pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)+45.86%
Earnings growth (this year)-15.71%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+168.41%
P/E ratioNM
Price/Sales5.45
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CHRSCoherus BioSciences ...+0.90+5.52%
NTLAIntellia Therapeutic...-0.60-2.03%
BOLDAudentes Therapeutic...+0.47+1.14%
AMAGAMAG Pharmaceuticals...+0.63+2.96%
Data as of 4:00pm ET, 06/22/2018

Financials

Next reporting dateJuly 27, 2018
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$115.4M
Annual profit (last year)-$96.0M
Net profit margin-83.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts